Patent · US Expired

Hybrid immunoglobulins

US5428130A · kind A · utility

347Cited by
1References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 8, 1992
Grant dateJun 27, 1995
Priority date
Expiry dateDec 8, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/705
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Novel polypeptides are provided, together with methods for making and using them, and nucleic acids encoding them. These polypeptides are useful as cell surface adhesion molecules and ligands, and are useful in therapeutic or diagnostic compositions and methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.